AGMB · Agomab Therapeutics NV
$14.28
+0.26 (+1.85%)
At close · Aug 26
Market Cap
$631.36M
Shares
49.25M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-20 | 103,167 | 101,919 | 205,086 | 48.1% |
| 2026-07-13 | 67,056 | 129,805 | 196,861 | 45.6% |
| 2026-07-06 | 86,395 | 60,616 | 147,011 | 41.8% |
| 2026-06-29 | 88,687 | 90,131 | 178,818 | 26.7% |
| 2026-06-22 | 122,232 | 147,890 | 270,122 | 47.4% |
| 2026-06-15 | 169,938 | 112,102 | 282,040 | 49.7% |
| 2026-06-08 | 266,268 | 160,456 | 426,724 | 56.9% |
| 2026-06-01 | 109,640 | 146,546 | 256,186 | 64.8% |
| 2026-05-25 | 39,306 | 72,047 | 111,353 | 56.4% |
| 2026-05-18 | 60,732 | 28,810 | 89,542 | 46.2% |
| 2026-05-11 | 79,249 | 124,756 | 204,005 | 47.8% |
| 2026-05-04 | 93,694 | 152,643 | 246,337 | 51.9% |
| 2026-04-27 | 72,737 | 116,030 | 188,767 | 37.3% |
| 2026-04-20 | 65,540 | 177,195 | 242,735 | 36.9% |
| 2026-04-13 | 155,901 | 597,316 | 753,217 | 53.8% |
| 2026-04-06 | 204,536 | 278,854 | 483,390 | 59.6% |
| 2026-03-30 | 47,700 | 618,884 | 666,584 | 49.5% |
| 2026-03-23 | 152,030 | 350,222 | 502,252 | 56.6% |
| 2026-03-16 | 187,974 | 272,233 | 460,207 | 51.5% |
| 2026-03-09 | 58,205 | 47,689 | 105,894 | 31.8% |
| 2026-03-02 | 113,784 | 79,369 | 193,153 | 37.6% |
| 2026-02-23 | 111,761 | 40,773 | 152,534 | 26.5% |
| 2026-02-16 | 146,387 | 56,298 | 202,685 | 26.1% |
| 2026-02-09 | 178,831 | 305,595 | 484,426 | 33.3% |
| 2026-02-02 | 543,366 | 114,333 | 657,699 | 27.8% |
Showing 1–25 of 25 weeks
Key facts
CIK
2020932
CUSIP
00860C102
13F (30d)
31 filings
31 filers
Visit website
Investor relations